Company intelligence / Profile preview

Econic Biosciences

London, England, United Kingdomeconicbio.com ↗

Ownership: Private
Employees: ~10
Development stage: Preclinical

Overview

The company has not yet reported clinical results; it remains in the preclinical stage, developing therapies to target ecDNA as a novel approach to treating cancers associated with poor outcomes due to oncogene amplification and tumor heterogeneity.

Therapeutic areas: Oncology
Modalities: Likely small molecules or biologics targeting extrachromosomal DNA (ecDNA)
Industry: Biotech

Partnerships

No major pharmaceutical partnerships publicly disclosed as of May 2025.

Beyond the preview

Go deeper on Econic Biosciences.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Econic Biosciences.

Explore the full profile